Intrinsic Alpha

Humana Inc.

NYSE:HUM

Medical - Healthcare Plans

Healthcare
$389.91 +0.19%

+$0.70 today

Market cap
$46.83B
Beta
0.77
P/E (TTM)
38.6
EPS (TTM)
$9.39
Dividend yield
0.98%
52W Low $163.11High $380.86

Volume 2.10M

Average 1.72M

Financial health

Humana Inc. financial health

Start with the overall verdict and the rule-based risk checks for HUM, then work through liquidity, debt, balance-sheet quality, and claims on cash.

Financial health snapshot

Mixed

The balance sheet looks mixed, so liquidity and debt trends deserve a closer read.

Cash and investments cover debt Healthy short-term liquidity Moderate leverage Interest cover is thin

Cash & Investments

$26.34B

Debt Cushion

$13.83B

Current Ratio

1.6x

Interest Coverage

0.3x

Risk checks

2 of 12 checks flagged

  • Debt repayment from cash flow

    16.7 yr

    Passes when: Free cash flow could repay all debt within 5 years.

  • Tangible equity base

    56.0%

    Passes when: Goodwill and intangibles are below 50% of equity.

  • Positive equity

    Positive

    Passes when: Shareholders’ equity is above zero.

  • Interest coverage

    2.6×

    Passes when: Operating income is at least 1.5 times interest expense.

  • Short-term liquidity

    1.6×

    Passes when: Current assets are at least 1 times current liabilities.

  • Near-term debt coverage

    26.5×

    Passes when: Cash and short-term investments cover debt due within 12 months.

  • Manageable net debt

    Net cash

    Passes when: Net debt is below 3 times EBITDA.

  • Debt growth versus revenue growth

    3.3% vs. 11.7%

    Passes when: Over three years, debt growth is no more than 5 percentage points above revenue growth.

  • Altman Z-score trend

    3.97 → 4.12

    Passes when: The Z-score is stable or rising, or stays above 2.99.

  • Stock-based compensation

    17.3%

    Passes when: Stock-based compensation is no more than 20% of operating cash flow.

  • Share dilution

    -1.9% per year

    Passes when: Diluted share count grows no more than 2% per year.

  • Dividend coverage

    57.4% of FCF

    Passes when: Free cash flow covers dividends.

Financial strength scores

How strong are the fundamentals over time?

Piotroski tests profitability, balance-sheet direction, and efficiency; Altman estimates bankruptcy risk. Compare the current scores with their fiscal-year history.

Financial strength scores

Piotroski F-Score and Altman Z-Score from the latest reported financials

Piotroski F-Score

Strong

8 / 9

Nine pass/fail tests of profitability, balance-sheet strength, and efficiency. 8–9 is strong, 0–3 is weak.

Altman Z-Score

Safe zone

4.74

Bankruptcy-risk model. Above 2.99 is the safe zone, 1.81–2.99 the grey zone, and below 1.81 the distress zone.

Score history

Piotroski F-Score and Altman Z-Score recalculated from each fiscal year's statements and year-end market value.

Piotroski: 8–9 strong, 4–7 average, 0–3 weak. Altman: above 2.99 safe, 1.81–2.99 grey, below 1.81 distress. Our calculation can differ slightly from the provider's current scores above.

Liquidity

Can it meet short-term obligations?

Check whether cash and current assets cover what falls due within a year without depending on fresh financing.

Cash & Equivalents

$6.93B

Q3 2026

3Y +18.2%1Y +0.6%

Quick Ratio

1.6x

Q3 2026

Current Ratio

1.6x

Q3 2026

Cash Ratio

0.3x

Q3 2026

Working capital

How quickly does cash come back?

Receivable, inventory, and payable days show how much cash the operating cycle ties up and whether that is changing.

Working capital and cash conversion

Annual days measures from year-end receivables, inventory, and payables against revenue and cost of revenue.

Working capital (Q3 2026)

$15.56B

Current assets − current liabilities

Days sales outstanding

9 d

+1 days vs. prior year

Days inventory outstanding

0 d

+0 days vs. prior year

Days payables outstanding

32 d

-5 days vs. prior year

Cash conversion cycle

-23 d

+6 days vs. prior year

Leverage

How much debt risk sits on the balance sheet?

Review total borrowings, debt relative to equity and assets, and whether operating profit covers interest costs.

Total Debt

$12.50B

Q3 2026

3Y -1.1%1Y -12.2%

Debt/Equity

0.7x

Q3 2026

Debt/Assets

0.2x

Q3 2026

Interest Coverage

0.3x

Q3 2026

Debt service

Can cash flow carry the debt?

Measure debt against EBITDA and free cash flow, see how much is due within 12 months, and follow debt and cash over time.

Debt service capacity

Can operating cash flow carry the debt, and how much is due soon?

Net debt

Net cash: $12.61B

Total debt − cash − short-term investments

Net debt / EBITDA

Net cash

Above 3× is elevated

Free cash flow / debt

6.0%

Share of debt one year of FCF could repay

Years to repay debt

16.7 yr

Total debt ÷ free cash flow

Operating cash flow / current liabilities

0.1×

Above 1× funds a year of obligations

Interest coverage

2.6×

Operating income ÷ interest expense

Debt maturity

Cash and short-term investments cover short-term debt 26.5×.

Due within 12 months$949MDue later$11.56B

Balance sheet as of Q3 2026; cash flows TTM to Q3 2026.

Debt and cash over time

Fiscal-year-end borrowings against liquid assets; net debt below zero means net cash.

Balance sheet cushion

How much room is there if conditions weaken?

Extra cash and investments, and the balance of assets against liabilities, give the company room when trading gets harder.

Long-Term Investments

$1.23B

Q3 2026

3Y -58.2%1Y +88.8%

Assets

$57.28B

Q3 2026

3Y +5.5%1Y +0.2%

Liabilities

$38.40B

Q3 2026

3Y +7.4%1Y +1.3%

Balance sheet quality

Who funds the assets, and how tangible is the equity?

Split the claims on assets between suppliers, lenders, customers, and shareholders, and see how much equity rests on goodwill and intangibles.

Balance sheet quality

Who funds the assets, and how much of the equity is tangible (Q3 2026).

Claims on $57.29B in assets

  • Payables16.4%
  • Short-term debt1.7%
  • Long-term debt20.2%
  • Deferred revenue0.5%
  • Other liabilities28.3%
  • Equity33.0%

Goodwill + intangibles

$10.55B

18.4% of total assets

Share of equity

56.0%

Above 50% leaves little tangible backing

Tangible equity

$8.28B

Equity left after writing off goodwill and intangibles

Deferred revenue

$270M

Customer prepayments: a liability settled by delivering service, not cash

Shareholder claims

What do shareholders take out of the cash?

Dilution, stock-based pay, dividends, and buybacks all draw on cash flow; check whether free cash flow funds them.

Shareholder claims on cash

Dilution, stock-based pay, and whether free cash flow funds what is returned to shareholders.

Diluted shares, yearly change

-1.9%

Compound annual rate from FY 2020 to FY 2025

Stock-based compensation

$231M

17.3% of operating cash flow

Dividends paid

$429M

TTM to Q3 2026

Dividend / free cash flow

57.4%

Above 100% means dividends exceed free cash flow

Buybacks

$152M

TTM to Q3 2026

Weighted diluted shares outstanding

Competitor health

How does Humana Inc. compare with peers?

Compare leverage, interest coverage, and liquidity ratios with similar companies.

Competitor Health

Peer financial health comparison

CompanyMarket CapD/ED/AssetsND/EBITDAInt. Cov.QuickCurrentCash

UnitedHealth Group Incorporated

UNH:NYSE

$365.09B0.830.252.344.740.790.790.21

CVS Health Corp.

CVS:NYSE

$114.32B1.240.368.633.330.630.840.10

Elevance Health Inc.

ELV:NYSE

$92.84B0.760.272.465.791.241.240.48

Cigna Corporation

CI:NYSE

$78.26B0.750.202.026.610.720.850.14

Centene Corp.

CNC:NYSE

$35.28B0.940.24Net cash—1.681.680.83

Molina Healthcare, Inc.

MOH:NYSE

$10.94B0.970.25Net cash4.071.691.690.58

Oscar Health, Inc.

OSCR:NYSE

$8.05B0.440.075.99—0.950.950.57

Alignment Healthcare, Inc.

ALHC:NASDAQ

$1.54B1.890.32Net cash0.931.741.741.21

Questions

Financial health questions

Common questions about HUM's balance sheet, answered from the reported figures.

Is HUM's balance sheet healthy?

Humana Inc. (HUM) has a current ratio of 1.65, a quick read on short-term liquidity.

How leveraged is HUM?

Debt to equity is 0.66, which helps judge how much financing risk sits on the balance sheet.